Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: FCL012
MIFTS: 51

Facial Paralysis

Categories: Neuronal diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Facial Paralysis

About this section

MalaCards integrated aliases for Facial Paralysis:

Name: Facial Paralysis 12 76 44 15 73
Facial Palsy 12 29 6 15
Bell Palsy 73

Classifications:

MalaCards categories:
Anatomical: Neuronal diseases
See all MalaCards categories (disease lists)
ICD10: 33


External Ids:

Disease Ontology 12 DOID:13934
ICD10 33 G51.0
MeSH 44 D005158
NCIt 50 C26769
Sources

Summaries for Facial Paralysis

About this section
MalaCards based summary : Facial Paralysis, also known as facial palsy, is related to bell's palsy and camurati-engelmann disease, and has symptoms including seizures, muscle weakness and tremor. An important gene associated with Facial Paralysis is TUBB3 (Tubulin Beta 3 Class III), and among its related pathways/superpathways is N-cadherin signaling events. The drugs Prednisolone phosphate and Prednisolone have been mentioned in the context of this disorder. Affiliated tissues include bone, testes and eye, and related phenotypes are cellular and nervous system

Wikipedia : 76 Facial nerve paralysis is a common problem that involves the paralysis of any structures innervated by... more...

Sources

Related Diseases for Facial Paralysis

About this section

Diseases related to Facial Paralysis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 294)
# Related Disease Score Top Affiliating Genes
1 bell's palsy 33.4 HOXB1 LIPN
2 camurati-engelmann disease 31.5 LRP5 TGFB1
3 acoustic neuroma 30.5 NF2 TGFB1
4 neuroma 30.5 NF2 TGFB1
5 neurofibromatosis, type ii 29.6 CADM1 NF2
6 hyperostosis 29.5 ANKH LRP5 TGFB1
7 facial palsy, congenital, with ptosis and velopharyngeal dysfunction 12.4
8 facial palsy, familial recurrent peripheral 12.3
9 recurrent peripheral facial palsy 12.2
10 congenital hereditary facial paralysis-variable hearing loss syndrome 12.2
11 deafness, conductive stapedial, with ear malformation and facial palsy 12.2
12 aortic arch interruption, facial palsy, and retinal coloboma 12.1
13 anotia facial palsy cardiac defect 12.1
14 urofacial syndrome 1 11.4
15 moebius syndrome 11.4
16 melkersson-rosenthal syndrome 11.4
17 geniculate herpes zoster 11.2
18 neurilemmoma 11.2
19 carey-fineman-ziter syndrome 11.2
20 facial paresis, hereditary congenital, 1 11.1
21 craniometaphyseal dysplasia, autosomal dominant 11.1
22 craniometaphyseal dysplasia, autosomal recessive 11.1
23 facial paresis, hereditary congenital, 3 11.1
24 familial amyloidosis, finnish type 11.0
25 osteopetrosis, autosomal recessive 1 10.9
26 osteopathia striata with cranial sclerosis 10.9
27 lethal congenital contracture syndrome 2 10.9
28 sclerosteosis 10.9
29 biotin-thiamine-responsive basal ganglia disease 10.9
30 amyloidosis, finnish type 10.9
31 pontine tegmental cap dysplasia 10.9
32 charlie m syndrome 10.9
33 otitis media 10.4
34 hemifacial spasm 10.3
35 herpes zoster 10.2
36 bone fracture 10.2
37 amyloid tumor 10.2 NF2 TUBB3
38 asthenopia 10.2 CADM1 LIPN
39 mastoiditis 10.2
40 herpes simplex 10.2
41 craniodiaphyseal dysplasia 10.1 LRP5 TGFB1
42 lattice corneal dystrophy 10.1 GSN TGFB1
43 lyme disease 10.1
44 ectropion 10.1
45 human immunodeficiency virus infectious disease 10.1
46 paralytic squint 10.1 CADM1 TUBB3
47 tetanus 10.1
48 premenstrual tension 10.1 LIPN LRP5
49 myoclonus and ataxia 10.1
50 parotitis 10.1

Comorbidity relations with Facial Paralysis via Phenotypic Disease Network (PDN): (show all 11)


Acute Cystitis Epilepsy, Focal, with Speech Disorder and with or Without Mental Retardation
Exposure Keratitis Hypertension, Essential
Ischemic Heart Disease Mechanical Ectropion
Myoclonus and Ataxia Paralytic Lagophthalmos
Parotid Gland Cancer Swallowing Disorders
Transient Cerebral Ischemia

Graphical network of the top 20 diseases related to Facial Paralysis:



Diseases related to Facial Paralysis
Sources

Symptoms & Phenotypes for Facial Paralysis

About this section

UMLS symptoms related to Facial Paralysis:


seizures, muscle weakness, tremor, generalized muscle weakness, back pain, pain, headache, hemiplegia, ophthalmoplegia, syncope, chronic pain, sciatica, facial paresis, vertigo/dizziness, sleeplessness, oral manifestations, facial palsy, upper motor neuron, facial palsy, lower motor neuron, hemifacial paralysis, flaccid muscle tone

MGI Mouse Phenotypes related to Facial Paralysis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.97 ANKH CADM1 GSN HOXA2 HOXB1 LRP5
2 nervous system MP:0003631 9.76 CADM1 GSN HOXA2 HOXB1 LRP5 NF2
3 craniofacial MP:0005382 9.73 ANKH HOXA2 HOXB1 LRP5 NF2 TGFB1
4 respiratory system MP:0005388 9.5 ANKH GSN HOXA2 HOXB1 NF2 TGFB1
5 skeleton MP:0005390 9.17 ANKH GSN HOXA2 HOXB1 LRP5 NF2
Sources

Drugs & Therapeutics for Facial Paralysis

About this section

Drugs for Facial Paralysis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 108)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 302-25-0
2
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-24-8 5755
3
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Not Applicable 2921-57-5
4
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 83-43-2 6741
5
Acyclovir Approved Phase 4,Not Applicable,Early Phase 1 59277-89-3 2022
6
Acetylcholine Approved Phase 4,Not Applicable 51-84-3 187
7
Lidocaine Approved, Vet_approved Phase 4,Not Applicable 137-58-6 3676
8
Prednisolone hemisuccinate Experimental Phase 4,Phase 3,Phase 2,Not Applicable 2920-86-7
9 Methylprednisolone acetate Phase 4,Phase 3,Phase 2,Not Applicable
10 Hormones Phase 4,Phase 3,Phase 2,Not Applicable
11 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Not Applicable
12 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Not Applicable
13 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable
14 Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable
15 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Not Applicable
16 Prednisolone acetate Phase 4,Phase 3,Phase 2,Not Applicable
17 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Not Applicable
18 Neuroprotective Agents Phase 4,Phase 3,Not Applicable
19 Antiemetics Phase 4,Phase 3,Phase 2,Not Applicable
20 glucocorticoids Phase 4,Phase 3,Phase 2,Not Applicable
21 Autonomic Agents Phase 4,Phase 3,Phase 2,Not Applicable
22 Protective Agents Phase 4,Phase 3,Not Applicable
23 valacyclovir Phase 4,Not Applicable
24 Antiviral Agents Phase 4,Not Applicable,Early Phase 1
25 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
26 incobotulinumtoxinA Phase 4
27 abobotulinumtoxinA Phase 4,Not Applicable
28 onabotulinumtoxinA Phase 4,Not Applicable
29 Cholinergic Agents Phase 4,Not Applicable
30 Neuromuscular Agents Phase 4,Not Applicable
31 Neurotransmitter Agents Phase 4,Not Applicable
32 Acetylcholine Release Inhibitors Phase 4,Not Applicable
33 Botulinum Toxins Phase 4,Not Applicable
34 Botulinum Toxins, Type A Phase 4,Not Applicable
35 Vaccines Phase 4,Phase 3,Phase 2
36 Immunologic Factors Phase 4,Phase 3
37 Anesthetics, Local Phase 4,Not Applicable
38 Diuretics, Potassium Sparing Phase 4,Not Applicable
39 Anti-Arrhythmia Agents Phase 4,Phase 3,Not Applicable
40 Central Nervous System Depressants Phase 4,Phase 3,Not Applicable
41 Sodium Channel Blockers Phase 4,Not Applicable
42 Anesthetics Phase 4,Phase 3,Phase 2,Not Applicable
43
Prednisone Approved, Vet_approved Phase 2, Phase 3,Not Applicable,Early Phase 1 53-03-2 5865
44
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 3 7487-88-9 24083
45
Nicardipine Approved, Investigational Phase 3,Phase 1 55985-32-5 4474
46
Phenol Approved, Experimental Phase 2, Phase 3 108-95-2 996
47 tannic acid Approved Phase 2, Phase 3,Phase 3
48
Benzocaine Approved, Investigational Phase 2, Phase 3,Phase 3 94-09-7, 1994-09-7 2337
49
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2, Phase 3,Not Applicable 1177-87-3
50
Dexamethasone Approved, Investigational, Vet_approved Phase 2, Phase 3,Not Applicable 50-02-2 5743

Interventional clinical trials:

(show top 50) (show all 82)
# Name Status NCT ID Phase Drugs
1 Scandinavian Bell's Palsy Study Completed NCT00510263 Phase 4 Prednisolone + placebo;Valaciclovir + placebo;Prednisolone + valaciclovir;Placebo + placebo
2 Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis Completed NCT03048383 Phase 4 OnabotulinumtoxinA Injectable Product;AbobotulinumtoxinA Injectable Product;Incobotulinumtoxin A Injectable Product
3 A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults Completed NCT01427309 Phase 4
4 Evaluation of Cortisone Treatment in Children With Acute Facial Nerve Palsy Not yet recruiting NCT03781700 Phase 4 Prednisolone;Placebo Oral Tablet
5 Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty Terminated NCT01833221 Phase 4 injection of 1% lidocaine, 2mL for facial nerve block
6 Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery Completed NCT00438087 Phase 3 methylprednisolone
7 Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801 Completed NCT01604746 Phase 3
8 Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial Completed NCT00059332 Phase 3 Magnesium Sulfate;Normal Saline
9 A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis Completed NCT02020889 Phase 3 Placebo
10 Intratympanic Steroid for Bell's Palsy Recruiting NCT03508440 Phase 2, Phase 3 Prednisone
11 Neuroprotectant for Hypertensive Intracerebral Hemorrhage Not yet recruiting NCT03546283 Phase 3 Placebos;Cattle Encephalon Glycoside and Ignotin
12 Multi-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone® Vaccine in Adults Aged 65 Years and Older Terminated NCT00976027 Phase 3
13 Antihypertensive Treatment of Acute Cerebral Hemorrhage-II Terminated NCT01176565 Phase 3 Intravenous nicardipine hydrochloride
14 Quadrant Versus Superficial Parotidectomy Withdrawn NCT01607866 Phase 2, Phase 3
15 Comparison of Antibiotic Therapy Alone or Combined With Corticosteroids for the Treatment of Nontuberculous Mycobacterial Cervicofacial Lymphadenitis in Children: A Randomized Double-Blind Placebo-Controlled Study Withdrawn NCT01614977 Phase 3 Methylprednisoline
16 Palliative Re-irradiation for Progressive Diffuse Intrinsic Pontine Glioma (DIPG) in Children Completed NCT01777633 Phase 1, Phase 2
17 Seasonal Flu Vaccine in Adult Transplant Recipients Completed NCT01258023 Phase 2
18 Contrastim Stroke Trial Completed NCT01049802 Phase 1, Phase 2
19 A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma Completed NCT01153763 Phase 2 GSK2118436
20 A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes Recruiting NCT02785120 Phase 2 TF0023
21 Activated Protein C in Acute Stroke Trial Terminated NCT00533546 Phase 2 Activated Protein C
22 Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome Terminated NCT01127503 Phase 2 Metyrosine;Placebo
23 Antihypertensive Treatment in Acute Cerebral Hemorrhage Completed NCT00415610 Phase 1 nicardipine
24 The Relationship Between Psychological Factors and Bell's Palsy Unknown status NCT01377766
25 Prednisone and Acupuncture for the Treatment of Facial Neuritis: a Multiple Center, CER in China Unknown status NCT01201642 Not Applicable Prednisolone
26 Two Different Surgical Methods of Blepharospasm Unknown status NCT02765113 Early Phase 1
27 Quantification, Analysis and Simulation of Facial Mimics Movements Unknown status NCT02002572 Not Applicable
28 Comparing the Behavior of the Cardiac Autonomic Regulation System During 24h in Patient Post Stroke and Controls Unknown status NCT02735616
29 Anthropometric Angular Measurement to Determine Muscle Tonus in Patients With Peripheral Facial Paralysis Completed NCT00903669
30 Microbiologic Findings of Acute Facial Palsy in Children Completed NCT01537952
31 Assessment of the Cross-face Nerve Graft in the Treatment of Facial Paralysis Completed NCT03006783
32 Steroid-Antiviral Treatment in Rehabilitation of Facial Palsy Completed NCT02328079 Not Applicable Steroids (Prednisolone) and Steroids plus Antiviral (Prednisolone + acyclovir)
33 Study of a New Technique to Improve the Symptoms of Orofacial Discomfort in Patients With Peripheral Facial Paralysis Completed NCT01327157 Not Applicable
34 Myofunctional Therapy in Facial Palsy Completed NCT00989209 Not Applicable Botulinum Toxin Type A
35 Randomized Controlled Trial of Acupuncture to Treat Bell's Palsy According to Different Stages Completed NCT00608660 Not Applicable
36 A Clinical Study on the Combined Magnetic and Oxygen Treatment for Bell's Palsy Completed NCT01686464 Not Applicable prednisone and valacyclovir treatments
37 Acupuncture With Deqi And Psychological Effects in Treatment of Bell's Palsy Completed NCT00685789 Not Applicable
38 Prednisone-Placebo vs Prednisone-Valacyclovir in Bell´s Palsy Completed NCT00561106 Not Applicable prednisone- valacyclovir;prednisone-placebo
39 Cognitive Function and Emotional Possessing in Bilateral Facial Palsy Completed NCT02179450
40 Complications in Parotid Surgery Completed NCT02486393
41 Retrospective Clinical Outcome of Parotid Tumor Surgery Completed NCT01983176
42 Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors Completed NCT02527226 Not Applicable
43 Clinical Research Core Dental Screening Protocol Completed NCT00090818
44 Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age Completed NCT01985997
45 National Prospective and Comparative Study on the Mode of Delivery of Twins Completed NCT01987063
46 Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines Completed NCT02893878
47 Acute Recanalization of Thrombo-Embolic Ischemic Stroke With pREset (ARTESp) Completed NCT02437409
48 REACT AGAINST STROKE Completed NCT02846363
49 General Anesthesia With or Without Local Ear Block in Middle Ear Surgeries Completed NCT03569046 Not Applicable local anaesthetic injection;Normal Saline Flush, 0.9% Injectable Solution;general anesthetic;Hypotensives
50 Ultrasound Evaluation of Tongue Movements in Speech and Swallowing Completed NCT00001167

Search NIH Clinical Center for Facial Paralysis

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: facial paralysis

Sources

Genetic Tests for Facial Paralysis

About this section

Genetic tests related to Facial Paralysis:

# Genetic test Affiliating Genes
1 Facial Palsy 29
Sources

Anatomical Context for Facial Paralysis

About this section

MalaCards organs/tissues related to Facial Paralysis:

41
Bone, Testes, Eye, Skin, Myeloid, Breast, B Cells
Sources

Publications for Facial Paralysis

About this section

Articles related to Facial Paralysis:

(show top 50) (show all 1827)
# Title Authors Year
1
Update on the ophthalmic management of facial paralysis. ( 29886125 )
2019
2
Slowly progressive facial paralysis: Intraneural squamous cell carcinoma of unknown primary. ( 30472126 )
2019
3
The Distal Stump of the Intramuscular Motor Branch of the Obturator Nerve Is Useful for the Reconstruction of Long-Standing Facial Paralysis Using a Double-Powered Free Gracilis Muscle Flap Transfer. ( 29381636 )
2018
4
Facial Paralysis Discussion and Debate. ( 29636148 )
2018
5
Societal Identification of Facial Paralysis and Paralysis Location. ( 29423522 )
2018
6
Speech and Communicative Participation in Patients With Facial Paralysis. ( 29955841 )
2018
7
Outcomes From Lateral Eyelid Coupling for Facial Paralysis Using the Modified Tarsoconjunctival Flap. ( 29621372 )
2018
8
Bilateral Post-Traumatic Facial Paralysis That Contains Longitudinal and Transverse Temporal Fracture. ( 29608481 )
2018
9
Functional outcomes assessment following free muscle transfer for dynamic reconstruction of facial paralysis: A literature review. ( 29628301 )
2018
10
Validation of the Clinician-Graded Electronic Facial Paralysis Assessment. ( 29596203 )
2018
11
Polyethylene glycol fusion associated with antioxidants: A new promise in the treatment of traumatic facial paralysis. ( 29522265 )
2018
12
Incomplete Facial Paralysis: The Use of the Ipsilateral Residual Facial Nerve as a Donor Nerve for Facial Reanimation. ( 29649064 )
2018
13
Comparison of symmetry after smile reconstruction for flaccid facial paralysis with combined fascia lata grafts and functional gracilis transfer for static suspension or gracilis transfer alone. ( 29603352 )
2018
14
The effects of lipoic acid and methylprednisolone on nerve healing in rats with facial paralysis<sup/>. ( 29310488 )
2018
15
Facial Paralysis in Patients With Hemifacial Microsomia: Frequency, Distribution, and Association With Other OMENS Abnormalities. ( 29771843 )
2018
16
Anxiety, depression, and hopelessness in patients before and after treatment for peripheral facial paralysis. ( 29940684 )
2018
17
Discussion: Incomplete Facial Paralysis: The Use of the Ipsilateral Residual Facial Nerve as a Donor Nerve for Facial Reanimation. ( 29952901 )
2018
18
Familial lower lip facial paralysis with asymmetric smile: Selective neurectomy of the cervical branch. ( 29728169 )
2018
19
Triple innervation for re-animation of recent facial paralysis. ( 29598895 )
2018
20
Hypoglossal-facial nerve &amp;quot;side&amp;quot;-to-side neurorrhaphy for facial paralysis resulting from closed temporal bone fractures. ( 29889081 )
2018
21
Quantifying Soft Tissue Shape and Symmetry: Patients with Cleft Lip/Palate and Facial Paralysis. ( 29707466 )
2018
22
Bilateral anterior uveitis and unilateral facial palsy due to ipilimumab for metastatic melanoma in an individual with human leukocyte antigen DR4: A case report. ( 28225147 )
2018
23
Bell's Palsy-Tertiary Ischemia: An Etiological Factor in Residual Facial Palsy. ( 30211092 )
2018
24
Systematic Review of Facial Nerve Outcomes After Middle Fossa Decompression and Transmastoid Decompression for Bell's Palsy With Complete Facial Paralysis. ( 30239428 )
2018
25
Post Temporal Bone Fracture Facial Paralysis: Strategies in Decision Making and Analysis of Efficacy of Surgical Treatment. ( 30464917 )
2018
26
Reply: Validation of the Clinician-Graded Electronic Facial Paralysis Assessment. ( 29596204 )
2018
27
Comparison of Functional Results After Cross-Face Nerve Graft-, Spinal Accessory Nerve-, and Masseter Nerve-Innervated Gracilis for Facial Paralysis Reconstruction: The Chang Gung Experience. ( 29668505 )
2018
28
Peripheral facial paralysis associated with HIV infection: A case series and literature review. ( 29990960 )
2018
29
Perfusion maintains functional potential in denervated mimic muscles in early persistent facial paralysis which requires early microsurgical treatment - the histoanatomic basis of the extratemporal facial nerve trunk assessing axonal load in the context of possible nerve transfers1. ( 30010114 )
2018
30
An Experimental Study on the Optimal Timing for the Repair of Incomplete Facial Paralysis by Hypoglossal-facial 'Side'-to-side Neurorrhaphy in Rats. ( 30025554 )
2018
31
Cross-Face Nerve Grafting versus Masseteric-to-Facial Nerve Transposition for Reanimation of Incomplete Facial Paralysis: A Comparative Study Using the FACIAL CLIMA Evaluating System. ( 30045184 )
2018
32
Acute peripheral facial paralysis following varicella infection: An uncommon complication. ( 30102488 )
2018
33
The surgical management of bilateral facial paralysis: case report. ( 30187838 )
2018
34
Surgery for post-traumatic facial paralysis: are we overdoing it? ( 30255202 )
2018
35
Medical Management of Acute Facial Paralysis. ( 30297178 )
2018
36
Management of Flaccid Facial Paralysis of Less Than Two Years' Duration. ( 30297179 )
2018
37
The Contribution of Surface Electromyographic Assessment for Defining the Stage of Peripheral Facial Paralysis: Flaccid or Sequelae Stage. ( 30357072 )
2018
38
Pediatric Bilateral Facial Paralysis: An Unusual Presentation of Lyme Disease. ( 30365410 )
2018
39
Bilateral facial paralysis associated with leptospirosis. ( 30369663 )
2018
40
Masseter-to-Facial Nerve Transfer for Reanimation of a Patient With Long-Term Facial Paralysis. ( 30480628 )
2018
41
A Network Meta-Analysis to Compare the Efficacy of Steroid and Antiviral Medications for Facial Paralysis from Bell´s Palsy. ( 30508985 )
2018
42
One-stage reconstruction by dual-innervated double muscle flap transplantation with the neural interconnection between the ipsilateral masseter and contralateral facial nerve for reanimating established facial paralysis: A report of 2 cases. ( 30512222 )
2018
43
Evaluation of the sensitivity of the Psychosocial Scale of Facial Appearance in peripheral facial paralysis. ( 30517273 )
2018
44
Blink Restoration in Long-standing Facial Paralysis: Use of Free Neurovascular Platysma Transfer. ( 30534494 )
2018
45
Facial Soft-tissue Mobility: Baseline Dynamics of Patients with Unilateral Facial Paralysis. ( 30534499 )
2018
46
Outcome of facial palsy from Lyme disease in prospectively followed patients who had received corticosteroids. ( 29720355 )
2018
47
Facial palsy: An unusual complication of vivax malaria. ( 30233026 )
2018
48
Risk Factors for Clinician-Diagnosed Lyme Arthritis, Facial Palsy, Carditis, and Meningitis in Patients From High-Incidence States. ( 29326960 )
2018
49
Facial palsy in a baby with acute otitis media. ( 28363956 )
2018
50
Delayed facial palsy following microvascular decompression for trigeminal neuralgia. ( 29540051 )
2018
Sources

Variations for Facial Paralysis

About this section
Sources

Expression for Facial Paralysis

About this section
Search GEO for disease gene expression data for Facial Paralysis.
Sources

Pathways for Facial Paralysis

About this section

Pathways related to Facial Paralysis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
N-cadherin signaling events 1
10.14 GSN LRP5
Sources

GO Terms for Facial Paralysis

About this section

Cellular components related to Facial Paralysis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cortical actin cytoskeleton GO:0030864 8.62 GSN NF2

Biological processes related to Facial Paralysis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 aging GO:0007568 9.58 GSN KRT83 TGFB1
2 myelination GO:0042552 9.46 MARVELD1 TGFB1
3 negative regulation of osteoblast differentiation GO:0045668 9.43 HOXA2 LRP5
4 oligodendrocyte development GO:0014003 9.37 GSN TGFB1
5 cell-cell junction organization GO:0045216 9.32 NF2 TGFB1
6 osteoblast development GO:0002076 9.26 HOXA2 LRP5
7 negative regulation of cell-cell adhesion GO:0022408 9.16 NF2 TGFB1
8 lens fiber cell differentiation GO:0070306 8.96 NF2 TGFB1
9 anterior/posterior pattern specification GO:0009952 8.8 HOXA2 HOXB1 LRP5
Sources

Sources for Facial Paralysis

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....